Compounds > ezetimibe
Page last updated: 2024-09-04

ezetimibe and mk-0524

ezetimibe has been researched along with mk-0524 in 2 studies

Compound Research Comparison

Studies
(ezetimibe)		Trials
(ezetimibe)		Recent Studies (post-2010)
(ezetimibe)		Studies
(mk-0524)		Trials
(mk-0524)		Recent Studies (post-2010) (mk-0524)
2,4845631,4651215771

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)mk-0524 (IC50)
Prostaglandin D2 receptorHomo sapiens (human)0.0007

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ansell, BJ1
Cabré, A; Masana, L; Plana, N1

Reviews

1 review(s) available for ezetimibe and mk-0524

ArticleYear
A review of trials evaluating nonstatin lipid-lowering therapies.
    Current atherosclerosis reports, 2009, Volume: 11, Issue:1

    Topics: Anticholesteremic Agents; Azetidines; Clinical Trials as Topic; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Indoles; Niacin

2009

Other Studies

1 other study(ies) available for ezetimibe and mk-0524

ArticleYear
HPS2-THRIVE results: bad for niacin/laropiprant, good for ezetimibe?
    Atherosclerosis, 2013, Volume: 229, Issue:2

    Topics: Adaptor Protein Complex 3; Adaptor Protein Complex beta Subunits; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Ezetimibe; Humans; Hypolipidemic Agents; Indoles; Niacin; Simvastatin

2013